Viewing nowCombinationAmojartan XQ Tablet 5/100/5/10 mg
Losartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202007694 · Approved 2020.11.09 · Insurance code 643508370
Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)
This medication is used for patients requiring treatment for hypertension and dyslipidemia. The combination of amlodipine and losartan is applicable for patients with essential hypertension who do not achieve adequate blood pressure control or when a combination is needed to reach treatment goals in Stage 2 hypertension. Meanwhile, the combination of atorvastatin and ezetimibe helps improve cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia and reduces the risk of atherosclerotic vascular disease. This medication should be used alongside an appropriate diet, and other conditions or secondary causes require treatment if necessary. Thus, it is used to effectively improve hypertension and dyslipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow the tablet whole without chewing, dividing, or crushing it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the anticipated likelihood of achieving the treatment goal with the combination compared with a single agent. The usual dose is amlodipine/losartan 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: Dose adjustment is not required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years or over, an initial losartan dose of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended initial dose is 5/10 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10 mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. Caution is required when administering to patients with reduced blood volume as hypotension may occur upon initiation. Patients with a risk of myopathy or rhabdomyolysis must inform their physician immediately if symptoms such as muscle pain or weakness occur during treatment. This medication should not be taken by individuals with hypersensitivity to any of its components or those with specific liver or kidney diseases. Elderly patients or those with very low blood pressure, as well as patients with hyperkalemia should take this medication with caution and require regular blood tests. Since this medication may affect liver function, patients with hepatic impairment should undergo liver function tests before and during treatment. As this medication includes statin components, muscle-related adverse reactions may occur; hence, if severe muscle pain or weakness develops, immediate consultation with a physician is necessary. Due to blood pressure-lowering effects, dizziness or fainting may occur; caution is advised while driving or operating machinery. There is a potential for drug interactions when using this medication with other antihypertensive agents or lipid-lowering drugs, so consultation with a physician is essential before use. Patients with lactose intolerance should not take this medication, and women of childbearing age must use adequate contraception while on this medication.
Craniosynostosis, anuria, hypotension, renal failure, elevated ALT, elevated AST, dermatitis, orthostatic dizziness, transmural nephritis, rhabdomyolysis, pancreatic adenocarcinoma, facial edema, strange sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, dizziness, somnolence, neurodegenerative disorders, migraine, diabetes, glucose tolerance impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver impairment, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, facial swelling, fever, orthostatic effects, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, anorexia, constipation, toothache, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper limb pain, hip pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, hypotonia, arthralgia, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorder, ataxia, confusion, nightmares, sensory impairment, decreased libido, memory impairment, neural hyperexcitability, sensory disturbance, peripheral neuropathy, panic disorder, sleep disorder, tremor, dyspnea, bronchitis, pharyngeal discomfort, epistaxis, rhinitis, respiratory congestion, chest discomfort, alopecia, dermatitis, dry skin, petechiae, erythema, flushing, photosensitivity reactions, pruritus, rash, sweating, urticaria, blurred vision, burning and pain in the eyes, conjunctivitis, dysgeusia, tinnitus, vision impairment, erectile dysfunction, nocturia, frequent urination, urethritis, benign esophageal neoplasm, angioedema, vasculitis, anaphylactoid syndrome, abnormal liver function, hepatitis, intestinal vascular edema, lethargy, thrombocytopenia, myalgia, weakness, elevated creatine kinase, elevated serum myoglobin, dysgeusia, dry cough, erythema multiforme, hyperkalemia, hyponatremia, elevated ALT, elevated AST, increased BUN, increased serum creatinine, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, renal failure, ventricular ectopic beats, atrial fibrillation, hypoglycemia, weakness, hunger, diaphoresis, tremors, decreased concentration, convulsion, altered consciousness, headache, dizziness, constipation, nausea, abdominal pain, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, eosinophilia with systemic symptoms drug reaction syndrome, Stevens-Johnson syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, elevated ALT, chest pain, cough, myalgia, elevated CK, constipation, elevated AST, weakness, joint pain, fatigue, numbness, sensory disturbance, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, arthralgia, elevated creatine phosphokinase, myopathy, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, cholelithiasis, cholecystitis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is essential to maintain the storage temperature between 1°C and 30°C at room temperature. This helps to preserve the efficacy and safety of the medication for a long time.
Pink oval film-coated tablet
30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.